Litcius/Paper detail

The DNA-topoisomerase Inhibitors in Cancer Therapy

Stefano Mastrangelo, Giorgio Attinà, Silvia Triarico, Alberto Romano, Palma Maurizi, Antonio Ruggiero

2022Biomedical & Pharmacology Journal39 citationsDOIOpen Access PDF

Abstract

DNA-topoisomerases are ubiquitous enzymes essential for major cellular processes. In recent years, interest in DNA-topoisomerases has increased not only because of their crucial role in promoting DNA replication and transcription processes, but also because they are the target of numerous active ingredients. The possibility of exploiting for therapeutic purposes the blocking of the activity of these enzymes has led to the development of a new class of anticancer agents capable of inducing apoptosis of tumor cells following DNA damage and its failure to repair.

Topics & Concepts

TopoisomeraseDNADNA damageDNA replicationEnzymeTranscription (linguistics)Cancer researchBiologyDNA repairCancer therapyTranscription factorChemistryCell biologyCancerBiochemistryGeneticsGenePhilosophyLinguisticsCancer therapeutics and mechanismsBioactive Compounds and Antitumor AgentsSynthesis and bioactivity of alkaloids